CELEXA Drug Patent Profile
✉ Email this page to a colleague
When do Celexa patents expire, and when can generic versions of Celexa launch?
Celexa is a drug marketed by Forest Labs and Abbvie and is included in two NDAs.
The generic ingredient in CELEXA is citalopram hydrobromide. There are fifty-six drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the citalopram hydrobromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Celexa
A generic version of CELEXA was approved as citalopram hydrobromide by AUROBINDO on October 28th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CELEXA?
- What are the global sales for CELEXA?
- What is Average Wholesale Price for CELEXA?
Summary for CELEXA
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 216 |
| Clinical Trials: | 54 |
| Patent Applications: | 4,096 |
| Drug Prices: | Drug price information for CELEXA |
| What excipients (inactive ingredients) are in CELEXA? | CELEXA excipients list |
| DailyMed Link: | CELEXA at DailyMed |
Recent Clinical Trials for CELEXA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Spaulding Clinical Research LLC | Phase 1 |
| Food and Drug Administration (FDA) | Phase 1 |
| Western University, Canada | N/A |
Pharmacology for CELEXA
| Drug Class | Serotonin Reuptake Inhibitor |
| Mechanism of Action | Serotonin Uptake Inhibitors |
US Patents and Regulatory Information for CELEXA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Forest Labs | CELEXA | citalopram hydrobromide | SOLUTION;ORAL | 021046-001 | Dec 22, 1999 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | CELEXA | citalopram hydrobromide | TABLET;ORAL | 020822-003 | Jul 17, 1998 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Abbvie | CELEXA | citalopram hydrobromide | TABLET;ORAL | 020822-001 | Apr 27, 2000 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Abbvie | CELEXA | citalopram hydrobromide | TABLET;ORAL | 020822-002 | Jul 17, 1998 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
